You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

CLINICAL TRIALS PROFILE FOR MIVACRON


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for MIVACRON

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01906528 ↗ Sex-related Differences in the Response to the Muscle Relaxant Drug Mivacurium Completed Oslo University Hospital Phase 1 2013-03-01 Muscle relaxants are drugs providing muscle relaxation during surgical treatment. Previous studies have shown that males and females respond differently to this kind of drug. Our hypothesis is that males are more sensitive to the effect of Mivacurium (a muscle relaxant) than females, meaning that males need a lower blood concentration of the drug than females in order to obtain a given effect.
NCT01906528 ↗ Sex-related Differences in the Response to the Muscle Relaxant Drug Mivacurium Completed University of California, San Francisco Phase 1 2013-03-01 Muscle relaxants are drugs providing muscle relaxation during surgical treatment. Previous studies have shown that males and females respond differently to this kind of drug. Our hypothesis is that males are more sensitive to the effect of Mivacurium (a muscle relaxant) than females, meaning that males need a lower blood concentration of the drug than females in order to obtain a given effect.
NCT02117401 ↗ A Prospective, Multi-center, Randomized Controlled Study of Muscle Relaxation Effect and Safety of Mivacurium Chloride in Pediatric Surgery Patients Completed Jiangsu Nhwa Pharmaceutical Co., Ltd. Phase 4 2012-01-01 To evaluate the effect and safety of mivacurium chloride in pediatric patients.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for MIVACRON

Condition Name

Condition Name for MIVACRON
Intervention Trials
Residual Paralysis 1
Sex 1
Anaesthesia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for MIVACRON
Intervention Trials
Fibrosis 1
Paralysis 1
Liver Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for MIVACRON

Trials by Country

Trials by Country for MIVACRON
Location Trials
United States 1
Czechia 1
Czech Republic 1
China 1
Belgium 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for MIVACRON
Location Trials
California 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for MIVACRON

Clinical Trial Phase

Clinical Trial Phase for MIVACRON
Clinical Trial Phase Trials
Phase 4 1
Phase 2 1
Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for MIVACRON
Clinical Trial Phase Trials
Completed 4
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for MIVACRON

Sponsor Name

Sponsor Name for MIVACRON
Sponsor Trials
Jiangsu Nhwa Pharmaceutical Co., Ltd. 2
Oslo University Hospital 1
University of California, San Francisco 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for MIVACRON
Sponsor Trials
Other 5
Industry 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.